Company Filing History:
Years Active: 2003
Title: Innovator Kent Halfdan Rokkjaer: Pioneering Medical Self-Treatment Systems
Introduction: Kent Halfdan Rokkjaer, based in Holstebro, Denmark, is an accomplished inventor recognized for his innovative contributions to the field of medical technology. With a focus on enhancing patient care, he holds a notable patent that aims to empower patients through self-treatment solutions.
Latest Patents: Rokkjaer's significant patent is titled "Medical system and a method of controlling the system for use by a patient for medical self-treatment." This invention presents a sophisticated system designed to facilitate medical self-treatment. It comprises several portable modules, among which one acts as a master module that oversees and monitors the entire operation. These modules include essential devices such as a blood glucose monitor (BGM), doser, inhaler, tablet dispenser, and a storage container. The system allows for data generation and storage, facilitating seamless communication with the master module. In the event the master module is out of range, the data is locally stored until connectivity is re-established, ensuring that essential patient information is never lost. Furthermore, the data can be transmitted to a computer or database for in-depth analysis, enabling healthcare professionals to provide informed guidance to the patient based on this data.
Career Highlights: Currently, Rokkjaer is associated with Novo Nordisk A/S, a leading global healthcare company specializing in diabetes care and other chronic conditions. His work focuses on leveraging technology to improve medical self-management, reflecting the innovative spirit of the company.
Collaborations: Throughout his career, Kent Halfdan Rokkjaer has collaborated with talented colleagues, including Jan Henning Simonsen and Jens Ulrik Poulsen. Together, they contribute to advancing medical technology that aligns with the ever-evolving needs of patients.
Conclusion: Kent Halfdan Rokkjaer exemplifies the role of an innovator in the medical field, showcasing how technology can be harnessed for improved patient self-care. His patent not only underscores his commitment to innovation but also highlights the vital contributions of his team at Novo Nordisk A/S. As the medical landscape continues to evolve, Rokkjaer’s work lays the foundation for future advancements in patient-centered medical solutions.